Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement

Leukemia

Volumn 11, Issue 9, 1997, Pages 1565-1570

  Billadeau, D ^a   Prosper, F ^a   Verfaillie, C ^a   Weisdorf, D ^c   Van Ness, B ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NONE

Author keywords

ASO PCR; Marrow; Myeloma; Peripheral blood; Transplant

Indexed keywords

ADULT; ARTICLE; BONE MARROW; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SEQUENTIAL ANALYSIS; STEM CELL TRANSPLANTATION;

EID: 0030766229     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400773     Document Type: Article

References (28)

1. Gobbi M, Cavo M, Savelli GA, Baccarani M, Tura S. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone. Haematologica 1985; 65: 437-442.
2. Vesole DH, Jagannath S, Glenn L, Barlogie B. Autotransplantation in multiple myeloma. Hematol Oncol Clin N Am 1993; 7: 613-630.
3. Jagannath S, Barlogie B, Dicke K, Alexanian R, Zagars G, Cheson B, Lemaistre F, Smallwood L, Pruitt K, Dixon D. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 1990; 76: 1860-1866.
4. Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken MM, Van Ness B. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 1992; 80: 1818-1824.
5. Witzig TE, Gertz MA, Pineda AA, Kyle RA, Greipp PR. Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. Br J Haematol 1995; 89: 640-642.
6. Jagannath S, Vesole DH, Tricot G, Crowley J, Salmon SE, Barlogie B. Hemopoietic stem cell transplants for multiple myeloma. Oncology 1994; 8: 89-103.
7. Fermand J, Chevret S, Levy Y, Miclea J, Tsapis A, Gerota J, Benbunan M, Brouet J. The role of autologous blood stem cells in support of high-dose therapy for multiple myeloma. Hematol Oncol Clin N Am 1992; 6: 451-462.
8. Witzig T, Gertz M, Lust J, Kyle R, Greipp P. Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest? Leuk Lymphoma 1995; 19: 417-422.
9. Bird JM, Bloxham D, Samson D, Marcus RE, Russell NH, Kelsey SM, Newland AC, Apperley JF. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br J Haematol 1994; 88: 110-116.
10. Billadeau D, Greipp P, Ahmann G, Witzig T, Van Ness B. Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS. Curr Topics Microbiol Immunol 1995; 194: 9-16.
11. Dreyfus F, Ribrag V, Leblond V, Ravaud P, Melle J, Quarre MC, Pillier C, Boccaccio C, Varet B. Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma. Bone Marrow Transplant 1995; 15: 707-711.
12. Fermand J-P, Chevret S, Ravaud P, Divine M, Leblond V, Dreyfus F, Mariette X, Brouet J-C. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 1993; 82: 2005-2009.
13. Bergsagel PL, Smith AM, Szczepek A, Mant MJ, Belch AR, Pilarski LM. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood 1995; 85: 436-447.
14. + monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991; 78: 711-719.
15. Pilarski L, Cass C, Tsuro T, Belch A. Multidrug resistance of a continuously differentiating monoclonal B lineage in the blood and bone marrow of patients with multiple myeloma. Curr Topics Microbiol Immunol 1992; 182: 177-185.
16. Pilarski L, Belch A. Circulating monoclonal B cells expressing P cycloprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 1994; 83: 724-736.
17. Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B. Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood 1991; 78: 3021-3029.
18. Gazitt Y, Reading CC, Hoffman R, Wickrema A, Vesole DH, Jagannath S, Condino J, Lee B, Barlogie B, Tricot G. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells. Blood 1995; 86: 381-389.
19. Gazitt Y, Tian E, Barlogie B, Reading CL, Vesole DH, Jagannath S, Schnell J, Hoffman R, Tricot G. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulo-cyte-macrophage colony-stimulating factor. Blood 1996; 87: 805-811.
20. Vescio RA, Hong CH, Cao J, Kim A, Schiller GJ, Lichtenstein AK, Berenson RJ, Berenson JR. The hematopoeitic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 1994; 84: 3283-3290.
21. Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma and active myeloma. Blood 1996; 88: 289-296.
22. Bird JM, Russell NH, Samson D. Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors. Bone Marrow Transplant 1993; 12: 651-654.
23. Deane M, Norton J. Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br J Haematol 1991; 77: 274-281.
24. Aubin J, Davi F, Nguyen SF, Leboeuf D, Debert C, Taher M, Valensi F, Canioni D, Brousse N, Varet B et al. Description of a novel FR1 1gH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 1995; 9: 471-479.
25. Billadeau D, Ahmann G, Greipp P, Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 1993; 178: 1023-1031.
26. Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder P. Structure of the human mu locus: characterization of embryonic and rearranged J and D genes. Cell 1981; 27: 583-591.
27. Ichihara Y, Matsuoka H, Kurosawa Y. Organization of human immunoglobulin diversity gene loci. EMBO J 1988; 7: 4141-4150.
28. Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, Wu CH, Cao J, Lee JC, Hong CH, Lichtenstein A, Lill M, Hall J, Berenson R, Berenson J. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.